RecruitingNCT07101796

Distribution of Mood and Personality Characteristics and Their Influence on Treatment Compliance

Sponsor

Peking University First Hospital

Enrollment

200 participants

Start Date

Sep 14, 2024

Study Type

OBSERVATIONAL

Conditions

Depression Anxiety Continuous Positive Airway Pressure (CPAP)Personality Patient Compliance

Summary

This study intends to investigate the personality and psychological characteristics of OSA patients using classical standard scales and obtain treatment information and adherence data through prospective follow-up to summarize the distribution characteristics of mood and personality characteristics of OSA patients and their influence on treatment adherence. A thorough understanding of OSA patient characteristics from the perspective of personality and psychological characteristics will be of great significance to the classification of OSA patients, precision treatment, and improving treatment compliance.

Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring how a person's mood and personality traits affect whether they stick with CPAP therapy — the standard breathing machine treatment for sleep apnea. **You may be eligible if...** - You are between 18 and 70 years old - You have symptoms of sleep apnea (such as snoring, waking up at night, or feeling sleepy during the day) or have already been diagnosed with sleep apnea - You are mentally alert and able to answer questions independently - You have agreed to participate in sleep monitoring or CPAP treatment **You may NOT be eligible if...** - You do not have sleep apnea symptoms or a diagnosis - You are unable to answer questions independently due to cognitive or behavioral limitations - You have not given informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.